×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Myeloma
Feature Video
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Jessica Skarzynski
Expanding a combination from two drugs to three may lengthen the time until disease progression for patients with relapsed or refractory multiple myeloma.
Katie Kosko
A dual-targeted chimeric antigen receptor-T cell therapy showed a more than 90% overall response rate in patients with relapsed or refractory disease.
Katie Kosko
JNJ-4528 showed deep responses and proved to be safe in patients with multiple myeloma, according to CARTITUDE-1 study findings.
Dr. Sham Mailankody
As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.
Katie Kosko
Meet four patients with multiple myeloma who have found hope and improved quality of life by participating in endurance events.
Katie Kosko
From new data released about CRISPR technology’s safety to Will Smith sharing his colonoscopy with the world, here’s what is making headlines in the cancer space this week.
Katie Kosko
College football anchor Rod Gilmore uses his voice to help raise awareness following a multiple myeloma diagnosis.
Jessica Skarzynski
For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
Katie Kosko
The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.
Katie Kosko and Jessica Skarzynski
Here’s a look at what’s inside our 2019 Hematology special issue.